1-2 of 2
Joseph Brandwein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

Jay M. Gamma, Qiang Liu, Erwan Beauchamp, Aishwarya Iyer, Megan C. Yap, Zoulika Zak, Cassidy Ekstrom, Rony Pain, Morris A. Kostiuk, John R. Mackey, Joseph Brandwein, Jean C.Y. Wang, Luc G. Berthiaume
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2025) 24 (1): 69–80.
https://doi.org/10.1158/1535-7163.MCT-24-0307
Published: 02 January 2025
View article titled, Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells
Open the PDF for Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells in another window
Includes: Supplementary data
Journal Articles

Abstract A106: A phase 1 study of ENMD‐2076 in patients with relapsed or refractory acute myeloid leukemia (AML)

Karen W. Yee, Joseph Brandwein, Mark D. Minden, Deborah Sanfelice, Sue Chow, David W. Hedley, Aaron D. Schimmer, Andre C. Schuh, Vikas Gupta, Carolyn F. Sidor, Jamie Arnott, Graham Fletcher, Mark Bray, Hsiao‐Wei Tina Chen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A106.
https://doi.org/10.1158/1535-7163.TARG-09-A106
Published: 10 December 2009
View article titled, Abstract A106: A phase 1 study of ENMD‐2076 in patients with relapsed or refractory acute myeloid leukemia (AML)